The funding round is led by global venture capital firm Antler and includes participation from prominent angel investors.
InnerGize plans to utilize the funds for manufacturing, clinical trials, R&D, and product launch in April 2025.
InnerGize's flagship product, InnerGize Gen 1, is a wearable device designed to tackle stress and anxiety through Neuroacoustic Vagal Modulation technology.